James Dilmore, Ph.D.

James Dilmore, Ph.D.



Jim focuses on patent prosecution, patent infringement litigation, and technology evaluation in support of product acquisition and launch. In patent prosecution, Jim prepares and prosecutes U.S. and foreign patent applications, working closely with inventors on both emerging and established technology to aid clients in developing patent portfolios.

Jim also extensively supports due diligence. By analyzing the strength and scope of patents through prior art searches, working with experts on technical issues, and reviewing legal implications of case law and prosecution history, Jim provides clients with valuable technical and legal support for intellectual property acquisition, protection, and commercialization.

Jim has extensive experimental background and training in neuroscience, pharmacology, cellular biology, and chemistry. Jim has supported patent infringement and trade secret litigation on DNA polymerase enzymes, bacterial expression systems, and parenteral pharmaceutical formulations. Such experience allows Jim to work seamlessly with clients on both technical and legal issues.

  • Supreme Court of Pennsylvania
  • United States District Court for the Western District of Pennsylvania
  • United States Patent & Trademark Office

  • Duquesne University School of Law, adjunct professor.
  • Clear Thoughts Foundation, chief scientific advisor.
  • Judge for local and international ISEF science fairs, 2012.
  • Duquesne Law Review, junior staff member, 2011-12; executive articles editor, 2012-13.
  • Duquesne Intellectual Property Law Association, member 2009, vice-president, 2010, president 2011-13.

  • Pittsburgh Intellectual Property Law Association, student writing award, 2012
  • CALI award, Administrative Law, 2012
  • CALI award, Patent and Trade Secret Law, 2011
  • CALI award, Constitutional Law, 2011
  • CALI award, Legal Research and Writing, 2010
  • Tau Beta Pi Engineering Honors Fraternity, 1993.
  • Eugene DuPont Distinguished Scholarship, University of Delaware, 1989-1993.

  • Duquesne University School of Law, J.D., 2013
  • University of Pittsburgh, 2000, Ph.D., Neuroscience, research focused on the modulation of ligand-and voltage-activated currents by dopamine and the neuropeptide somatostatin.
  • University of Pittsburgh, 1996, M.S., Neuroscience, research focused on inhibition of NMDA-activated currents by analogs of phencyclidine.
  • University of Delaware, 1993, B.S., Chemical Engineering, performed research into the ultracentrifugal crystallization of proteins.

Reed Smith LLP, Patent Agent, Intellectual Property (2001 - 2013)